Company Inspyr Therapeutics, Inc. Other OTC
Equities
NSPX
US45782A4031
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Silvestre Raul
CEO | Chief Executive Officer | 53 | - |
Michael Elliott
CTO | Chief Tech/Sci/R&D Officer | - | 11/16/11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Ogilvie
BRD | Director/Board Member | 69 | 01/08/01 |
Silvestre Raul
CEO | Chief Executive Officer | 53 | - |
Claire Thomas
BRD | Director/Board Member | 68 | 12/16/12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 5,000 | 0 | 0 | 100.00 % |
Stock B | 0 | 5,000 | 0 | 0 | |
Stock C | 0 | 290 | 0 | 0 | |
Stock D | 0 | 71 | 0 | 0 | |
Stock E | 0 | 134 | 0 | 0 | |
Stock F | 1 | 32,132,907 | 32,132,903 ( 100.00 %) | 0 | |
Stock G | 0 | 8,000 | 0 | 0 |
Company contact information
Rebus Holdings, Inc.
2629 Townsgate Road Suite 215
91361, Westlake Village
+818-661-6302
http://www.inspyrtherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+18.95% | 125B | |
+14.11% | 108B | |
-3.69% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-11.98% | 16.5B | |
+2.82% | 13.39B | |
+27.44% | 11.1B |